Mr. Higgins joined the Akonni Biosystems Board in 2011 and has served as Akonni’s Chairman of the Board since 2013. He is a member of the Board of Directors for Prosetta Biosciences, Inc., a biotech drug development company. Mr. Higgins also served as Prosetta’s founding President and CEO from 2003-2008. Before that time, Mr. Higgins was President and Chief Operating Officer of Business for Social Responsibility (BSR). BSR is the leading global resource for businesses seeking to improve their performance in areas of corporate social responsibility. Mr. Higgins served in the administration of President Carter, beginning as a senior executive at the Department of Health Education and Welfare, where he was Director of Region VII, and at HHS, as Associate Commissioner of the Social Security Administration. His service culminated as a presidential appointee on the White House Senior Staff, where he served as Deputy Secretary to the Cabinet. Mr. Higgins has served as a senior vice president of Edison International and its subsidiary, Southern California Edison, and as a Senior Vice President of Blue Cross and Blue Shield of MD. Earlier in his career, he was head of the health department in Portland, Oregon; founding publisher of the Portland Business Journal; co-founder and Editor in Chief of HealthWeek Publications; and a three term state representative in Iowa. Mr. Higgins currently serves on the boards of directors of Zen Hospice Project, C-TAC, SCAN Health Plan and The SCAN Foundation. He is a member of the Board of Trustees of St. Ambrose University, where he graduated cum laude in 1967. He is also a co-founder and chairman of the board of Amber Kinetics, an energy storage company in Union City, Ca.
Michael Farmer served as the Chairman of the Board of Akonni Biosystems from 2004 to 2012. Michael recently retired from Prosetta Biosciences having served as President and Co-CEO for 13 years. Prior to joining Prosetta as a startup, he served as President and CEO of HandyLab, a biotech located in Ann Arbor MI. Previously, Mr. Farmer was COO of Veridian, a billion-dollar defense contractor that operated the world’s most advanced cyber security tools and services for protecting the most sensitive computer networks for government agencies. He was the managing partner in WindRiver Group, a professional consulting firm that provided strategic advice to senior management in both major companies and smaller growth and start-up companies. As President and CEO of Infotronics and COO of its parent, American Medical Communications, Houston-based medical communications and information companies, Mr. Farmer brought these $10 million companies to profitability within one year after a six-year history of losses. Mr. Farmer also co-founded Age Wave, a firm that consults with Fortune 500 business leaders and government agencies in the challenges and opportunities of the aging of America. He was COO of the Hospital Satellite Network (HSN) during its startup years. As Executive Vice President of Harbridge House, the Boston-based management consulting firm formed by professors from the Harvard Business School, Mr. Farmer headed up the firm’s national healthcare and defense practices over a ten-year period. Following initial college graduation, Michael worked as an engineer holding various classified positions in the Department of Defense and intelligence agencies. During those ten years, he lived in Hawaii, the South Pacific and Southeast Asia, principally worked with high technology Navy engineering systems and communications and computer systems. He also attended extensive nuclear power training, U.S. Navy diving training, and earned a pilot license while on assignment within the Naval Sea Systems Command. He holds degrees in engineering and business. Michael has been a moderator at the Aspen Institute wherein he graduated from the Institute’s flagship Executive Leadership Development Program and has served as a guest lecturer in Harvard’s Advanced Management Program, at the Haas School of Business Administration at University of California Berkeley and at the University of Michigan’s MBA graduate program.
Mr. Keys serves as an Independent Financial and Operations Consultant. His current engagements include financial and operational oversight of a substantial real estate holdings and development company, commercial ranch and farming operations and a large investment portfolio of a number of startup and early stage companies. David began his career with Deloitte (one of the now Big 4 accounting firms) serving in the audit group in the Las Vegas and New York City executive offices. David was the Executive Vice President and CFO of American Pacific Corporation, a publicly traded chemical company for a number of years. Mr. Keys currently serves as Chairman of the Board and Audit Committee of RSI International Inc., a public company traded under the symbol RSY on the TSVX Exchange. He previously served on the Boards of Directors of two other publicly traded companies, AmFed Financial (NASDAQ) and American Pacific Corporation (NASDAQ). David was a member of the executive committee of the American Pacific Board of Directors. He was a member of the Boards of Directors of Norwest Bank of Nevada and Wells Fargo Bank of Nevada. Mr. Keys previously served on the Advisory Board of Directors of FM Global (formerly Factory Mutual Insurance), a leading provider of property and casualty insurance. He currently serves on the Board of Directors of a number of privately held companies including Prosetta Biosciences Inc. (Audit Committee Chair), Hauls Inc., Skywire Media Inc. (Chairman of the Board and Interim CEO), Walker Digital Table Systems LLC and Coast Flight Training and Management Inc. David is a Certified Public Accountant (CPA), Certified Valuation Analyst (CVA), Certified Management Accountant (CMA), Certified in Financial Forensics (CFF), Chartered Global Management Accountant (CGMA), Certified Information Technology Professional (CITP) and Certified in Financial Management (CFM). Mr. Keys is a member of the National Roster of Neutrals (sometimes referred to as the Commercial Panel) of the American Arbitration Association and has served as the sole arbitrator and as a member of a panel of three arbitrators on several cases in the Western United States, principally involving contract and valuation disputes. He received a Bachelor of Science degree in Accounting from Oklahoma State University in 1978. Mr. Keys joined the Akonni Biosystems Board in 2014.
Mr. McMahon serves as the President & CEO of CUBRC Inc., an independent, scientific not-for-profit (501c3) corporation, and of Avarint, LLC, its wholly-owned subsidiary. He has 32 years of experience in cultivating, securing, performing and managing highly diverse research, development, testing and integration programs and businesses focused on developing and advancing leading-edge technologies and systems in the areas of high speed aeronautics, public transportation and safety, data science and information fusion, modeling and simulation and (his personal area of expertise) chemical, biological and biomedical sciences. As President & CEO, he is ultimately responsible for all of CUBRC’s and Avarint’s strategic planning, program development activities, technical and business operations, infrastructure, compliance and financial performance. Outside of CUBRC, Mr. McMahon served from 2006 to 2009 as a Director on the Board of Prosetta Biosystems, Inc., a viral therapeutics start-up; has served as a Director of the Hauptman-Woodward Medical Research Institute since 2011; serves as a Director of HarkerBio, LLC since earlier this year; and has served as a Director of Trove Predictive Data Science since 2014. Mr. McMahon has a B.S. degree in Chemistry from St. Bonaventure University and an M.B.A. in Finance from Canisius College. Mr. McMahon joined the Akonni Biosystems Board in 2005.
Mr. Parrish, formerly Co-founder and Executive Vice President of Phone.com (PHCM) in Redwood City, California, is now a private investor and advisor to several technology companies. Before Openwave, Mr. Parrish was Vice President of marketing and General Manager of Mobile Data for GTE Mobile Communications (now Verizon (VZ). Prior to that, he was Senior Vice President of operations at Contel Cellular, Inc. and Co-founder and CEO of AmeriCom Corp in Atlanta. Mr. Parrish also served as Chief of Staff in the US Department of Interior during the Carter Administration, Carter/Mondale Texas Campaign Manager during the 1976 general election and National Field Director during the 1979-1980 Carter/Mondale primary campaign. Mr. Parrish served as a Division Director in the Georgia Department of Natural Resources under Governors Jimmy Carter and George Busbee. Mr. Parrish is a member of the Boards of CoEfficient LLC in Oakland CA; Akonni Biosystems in Frederick, MD; and Prosetta Biosciences (observer). He is a former Board Member of Novarra, Inc. (now Nokia), in Itasca, IL; the Corporation for Enterprise Development, in Washington, DC; and the Family Independence Initiative in Oakland, CA (Founding Chair). Mr. Parrish is married with two grown children and splits his time between Sarasota, FL and Martha’s Vineyard, MA. Mr. Parrish joined the Akonni Biosystems Board in 2009.
Mary A. Pittman, DrPH, is Chief Executive Officer and President of the Public Health Institute (PHI) in Oakland, California, one of the 15 largest non-profits in the Bay Area. Throughout her career, she has spearheaded efforts to align health care and public health sectors into order to improve population health and build equity. She is nationally recognized for her leadership in improving community health, addressing health inequities among vulnerable people and promoting prevention and quality of care. During her tenure, PHI has expanded their global portfolio, emphasizing women and girl’s empowerment and NCDs. PHI has expanded their research and data strategies to improve population health and equity, built strong web-based education through Dialogue4Health, built robust public-private partnerships, and has been recognized as one of the 50 best nonprofit workplaces in the nation. Pittman emphasizes the use of multi-sectoral models for community engagement and community building, incorporating innovative data and communication tools. She serves on numerous national boards and commissions. Pittman previously headed the Health Research and Educational Trust, an affiliate of the American Hospital Association, and the California Association of Public Hospitals.
Myun Ki Han, Ph.D. joined the Akonni Biosystems Board in 2019. He is currently the Executive Director of the Korea – U.S. Science Cooperation Center (KUSCO), and the Director General of the Korea Innovation Center (KIC). He received his Bachelors of Arts degree in Biochemistry and Cell Biology from the University of California San Diego, in La Jolla, CA in 1982. He then continued his education at The Johns Hopkins University in Baltimore, MD, earning his Ph.D. in Biochemistry and Biophysics in 1988. He was a faculty member at Johns Hopkins University and Georgetown University Medical Center. He has also held multiple positions in industry. He began as a Staff Fellow in the Laboratory of Biochemistry at the NHLBI. Later he was a member of the Advisory Committee of the Global AIDS and Cancer Foundation, then the Director of Kwang Dong Pharmaceutical Research Laboratories. More recently, he was the President and CEO of Excimus Biotech, and on the Board of Directors of KUSCO as the Chairman of the Finance Committee. In addition to his current leadership roles at KUSCO and KIC, he is also the Managing Director of JoEn Enterprise LLC. Dr. Han has a long history of significant contributions to the scientific community in his work on a wide variety of fluorescence techniques to study reaction kinetics, subunit interactions, reversible DNA strand separation, and structural analysis. His early career work involved the reaction kinetics of the bacterial phosphotransferase system and a thorough study of HIV-1 processing activities. Dr. Han also researched and patented fluorescent assays for DNA cleavage, including a fluorescence study on reversible strand separation. He developed the patented CataCleave cyclic probe technology which can detect SNPs, insertions, and deletions; identify target DNA through fluorescent amplification; and provide real-time monitoring of both isothermal and temperature-cycling nucleic amplification methods. Dr. Han is an experienced professional with thorough understanding of multiple areas of fluorescent biochemistry, DNA analysis, and protein structure research.
TruDiagnosis Systems, TruDx Readers, TruArray Tests, TruTip Kits, Primers, Lysis and Binding Buffers, Wash Buffers and Elution Buffers: For Research Use Only. Not for use in diagnostic procedures. No claim or representation is intended to provide information for the diagnosis, prevention or treatment of a disease.